Assignee
THERION BIOLOG CORP
US·13 granted patents·1 pending application·670 citations·filing 1988–2003
Top patents by PatentIndex Score
14 records- 0189US5656465AMethods of in vivo gene deliveryTHERION BIOLOG CORP·Filed 1994·Granted Aug 12, 1997·136 cites·26 claims
- 0288US5242829ARecombinant pseudorabies virusTHERION BIOLOG CORP·Filed 1990·Granted Sep 7, 1993·102 cites·3 claims
- 0385US5905040AParvovirus empty capsidsTHERION BIOLOG CORP·Filed 1991·Granted May 18, 1999·115 cites·15 claims
- 0483US5093258ARecombinant fowlpox virus and recombination vectorTHERION BIOLOG CORP·Filed 1988·Granted Mar 3, 1992·70 cites·20 claims
- 0581US6165460AGeneration of immune responses to prostate-specific antigen (PSA)THERION BIOLOG CORP·Filed 1995·Granted Dec 26, 2000·43 cites·17 claims
- 0679US6001349AGeneration of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereofTHERION BIOLOG CORP·Filed 1995·Granted Dec 14, 1999·38 cites·12 claims
- 0777US6319496B1Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereofTHERION BIOLOG CORP·Filed 1999·Granted Nov 20, 2001·24 cites·16 claims
- 0874US6699475B1Recombinant pox virus for immunization against tumor-associated antigensTHERION BIOLOG CORP·Filed 1995·Granted Mar 2, 2004·41 cites·7 claims
- 0969US5420026ASelf-assembling replication defective hybrid virus particlesTHERION BIOLOG CORP·Filed 1993·Granted May 30, 1995·32 cites·37 claims
- 1064US5747324ASelf-assembled, defective, non-self-propagating lentivirus particlesTHERION BIOLOG CORP·Filed 1992·Granted May 5, 1998·25 cites·18 claims
- 1157US6051410ASelf-assembled, defective, nonself-propagating viral particlesTHERION BIOLOG CORP·Filed 1997·Granted Apr 18, 2000·15 cites·7 claims
- 1256US5804196ASelf assembled, defective, nonself-propagating viral particlesTHERION BIOLOG CORP·Filed 1995·Granted Sep 8, 1998·16 cites·6 claims
- 1355US5736368ASelf assembled defective non-self propagating lentiviral particlesTHERION BIOLOG CORP·Filed 1995·Granted Apr 7, 1998·13 cites·7 claims
- 1451US2004101522A1Transduced neoplastic cell preparations able to express T-cell costimulatory molecules B7.1, ICAM-1, and LFA-3 and induce immunostimulatory prophylactic and therapeutic anti-tumor effects in-vivoTHERION BIOLOG CORP·Filed 2003·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →